UNSPSC 51314387: Acetaminophen/dextromethorphan/doxylamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE509. This VA Drug Class (RE509) classifies this compound as belonging to the group ANTIHISTAMINE/ANTITUSSIVE/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51314387 Acetaminophen/dextromethorphan/doxylamine is a Commodity code that in recent practice names over-the-counter and generic pharmaceutical products distributed through state and local health systems, purchasing cooperatives, and emergency-response programs. State and local governments procure under this code primarily for public health initiatives, county health departments, and multi-state cooperative purchasing programs that serve state agencies and local government facilities. The work solicited includes supply of generic pharmaceuticals and OTC products through authorized wholesaler networks, with vendors required to meet FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) adherence, and specific insurance and performance standards. Issuing bodies include county health departments, state health and human services agencies, and state purchasing cooperatives that aggregate demand across multiple jurisdictions.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for its Community Health Building, with quarterly deliveries and fixed-fee pricing on a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels, signaling exploration of alternative supply models. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026 (response due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring vendor pricing through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with evaluation weighted 75 percent on price competitiveness and contract effectiveness July 1, 2026.